UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies

Leukemia, 2015-08, Vol.29 (8), p.1754-1762

2015

Volltextzugriff (PDF)

Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis

Bone marrow transplantation (Basingstoke), 2017-12, Vol.52 (12), p.1616-1622

2017

Volltextzugriff (PDF)

Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors

Bone marrow transplantation (Basingstoke), 2012-10, Vol.47 (10), p.1283-1286

2012

Volltextzugriff (PDF)

Plerixafor 'just in time' for stem cell mobilization in a normal donor

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.1026-1027

2011

Volltextzugriff (PDF)

Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy

Blood, 1993-04, Vol.81 (8), p.2031-2035

1993

Volltextzugriff (PDF)

Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome

Seminars in hematology, 1997-04, Vol.34 (2), p.126-133

1997

Volltextzugriff (PDF)

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation : possible beneficial use of low molecular weight heparin

Bone marrow transplantation (Basingstoke), 2001-03, Vol.27 (6), p.627-633

2001

Volltextzugriff (PDF)

Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies

Journal of clinical oncology, 1997-01, Vol.15 (1), p.18-25

1997

Volltextzugriff (PDF)

Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Leukemia, 2020-12, Vol.34 (12), p.3338-3347

2020

Volltextzugriff (PDF)

Transplantation of Enriched and Purged Peripheral Blood Progenitor Cells From a Single Apheresis Product in Patients With Non-Hodgkin's Lymphoma

Blood, 1995-06, Vol.85 (11), p.3334-3341

1995

Volltextzugriff (PDF)

Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation

Blood, 1994-09, Vol.84 (5), p.1680-1684

1994

Volltextzugriff (PDF)

Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donor

Bone marrow transplantation (Basingstoke), 2008-04, Vol.41 (7), p.675-676

2008

Volltextzugriff (PDF)

Inside discrete-event simulation software: How it works and why it matters

2015 Winter Simulation Conference (WSC), 2015, p.1-15

2015

Volltextzugriff (PDF)

Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation

Bone marrow transplantation (Basingstoke), 1999-12, Vol.24 (12), p.1311-1314

1999

Volltextzugriff (PDF)

Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies

Bone marrow transplantation (Basingstoke), 2004-06, Vol.33 (11), p.1123-1129

2004

Volltextzugriff (PDF)

The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation

American journal of neuroradiology : AJNR, 1998-04, Vol.19 (4), p.601-608

1998

Volltextzugriff (PDF)

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee

Biology of blood and marrow transplantation, 2016-11, Vol.22 (11), p.1915-1925

2016

Volltextzugriff (PDF)

Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis

Transplantation and cellular therapy, 2022-10, Vol.28 (10), p.681-693

2022

Volltextzugriff (PDF)

High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome

British journal of cancer, 2001-06, Vol.84 (12), p.1591-1598

2001

Volltextzugriff (PDF)

How discrete-event simulation software works and why it matters

Proceedings of the 2012 Winter Simulation Conference (WSC), 2012, p.1-15

2012

Volltextzugriff (PDF)

Inside discrete-event simulation software: How it works and why it matters

2013 Winter Simulations Conference (WSC), 2013, p.424-438

2013

Volltextzugriff (PDF)

Interferon‐α‐associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy

Cancer, 1998-11, Vol.83 (9), p.1938-1946

1998

Volltextzugriff (PDF)

Inside discrete-event simulation software: How it works and why it matters

Proceedings of the 2011 Winter Simulation Conference (WSC), 2011, p.80-94

2011

Volltextzugriff (PDF)

1 – 25 von 318

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(255)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(186)
Physical Sciences
(82)
Technology
(69)
Physics
(63)
Humans
(57)
Life Sciences & Biomedicine
(56)
Chemistry
(50)
Engineering
(49)
Chemistry, Physical
(44)
Adult
(40)
Physics, Nuclear
(40)
Hematology
(39)
Computer Science
(36)
Engineering, Electrical & Electronic
(35)
Female
(34)
Male
(34)
Middle Aged
(31)
Transplantation
(31)
Immunology
(28)
Biological And Medical Sciences
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies

Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis

Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors

Plerixafor 'just in time' for stem cell mobilization in a normal donor

Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy

Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma

Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation : possible beneficial use of low molecular weight heparin

Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies

Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Transplantation of Enriched and Purged Peripheral Blood Progenitor Cells From a Single Apheresis Product in Patients With Non-Hodgkin's Lymphoma

Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation

Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donor

Inside discrete-event simulation software: How it works and why it matters

Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report

Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation

Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies

The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee

Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis

High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome

How discrete-event simulation software works and why it matters

Inside discrete-event simulation software: How it works and why it matters

Interferon‐α‐associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy

Inside discrete-event simulation software: How it works and why it matters

Suchergebnisse filtern